Abstract |
The therapeutic efficacy and safety of norfloxacin 400 mg twice daily for 3 or 7 days was compared in a double-blind randomized multiclinic study including 485 female general practice patients with uncomplicated symptomatic lower urinary tract infections. 373 patients were considered valid for efficacy, 193 in the 3-day treatment group and 180 in the 7-day treatment group. The short-term efficacy (elimination of significant bacteriuria 3-13 days post-treatment) was 93.8% and 96.6% in the 3 and 7-day treatment groups, respectively, and the accumulated efficacy (elimination of significant bacteriuria 3 days post-treatment up until 45 days after the first dose) 81.3% and 91.7%, respectively (p less than 0.004). The median time to disappearance of symptoms was 3 days in both groups. Norfloxacin was well tolerated in both treatment groups.
|
Authors | |
Journal | Scandinavian journal of infectious diseases
(Scand J Infect Dis)
Vol. 20
Issue 6
Pg. 619-24
( 1988)
ISSN: 0036-5548 [Print] England |
PMID | 2906171
(Publication Type: Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
|
Chemical References |
|
Topics |
- Bacteriuria
- Double-Blind Method
- Drug Administration Schedule
- Female
- Humans
- Middle Aged
- Norfloxacin
(administration & dosage, adverse effects, therapeutic use)
- Random Allocation
- Time Factors
- Urinary Tract Infections
(drug therapy)
|